NURSl 5463/l NURS5463l Examl 3l (Newl
2026/l 2027l Update)l Adultl Gerontologyl
Acutel Carel Guide|l Questionsl &l Answersl
|l Gradel A|l 100%l Correctl (Verifiedl
Solutions)-l UTA
QUESTION
clinicall pearlsl forl MRSA
Answer:
treatl withl vancomycin,l linexolid,l daptomycin
clindamycin,l trimethoprim/sulfamethoxazole,l andl rifampinl mayl bel usedl too
QUESTION
riskl factorsl forl VRE
Answer:
recentl usel ofl vancomycin,l cephalosporinsl orl quinolonesl
prolongedl hospitalizationl
icul admission
severelyl ill
QUESTION
clinicall pearlsl forl VRE
Answer:
treatl withl ampicillinl ifl sensitive,l linezolid,l daptomycin
mayl colonizel thel skin,l woundsl orl rectum
,QUESTION
beta-lactamasel producingl bacterial riskl factors
Answer:
B-lactamasesl arel enzymesl producedl byl somel bacterial whichl confersl resistantl tol betal
lactaml antibioticsl byl cleavingl thel antibioticl andl makingl itl ineffective
3l types,l ESBL,l Ampl C,l andl carbapenemases
QUESTION
extendedl spectruml b-lactamasesl (ESBL)l riskl factors
Answer:
prolongedl hospitalization
nursingl homel resident
usel ofl thirdl genl cephalosporins,l aztreonam
gutl colonization
inwellingl catheter
severityl ofl illness
QUESTION
extendedl spectruml b-lactamasesl commonl diseases
Answer:
escherichial spp.l andl klebsiellal spp.l arel thel mostl commonl producersl
confersl resistancel tol cegriaxone,l cefazidime,l cefotacime,l aztreonam,l andl penicillins
QUESTION
extendedl spectruml b-lactamasesl clinicall pearls
Answer:
treatmentl ofl choicel isl carbapenems
, QUESTION
carbapenemasesl (akal carbapeneml resistant)l riskl factors
Answer:
thesel bacterial tenl tol colonizel andl infectl patientsl withl multiplel co-morbidities,l ICUl
patientsl andl thosel withl prolongedl hospitlaization
QUESTION
carbapenemasesl commonl diseases
Answer:
klebsiellal spp.l isl thel mostl commonl producerl butl itl mayl bel producedl byl e.l colil .
enterobacterl spp.l pseudomonasl spp.l andl salmonella
QUESTION
carbapendemasesl clinicall pearls
Answer:
treatl withl Colistin.l Tigecyclinel mayl bel anl optionl
IDl consultation
QUESTION
Amp-l Cl B-lactamasesl producingl bacterial riskl factors
Answer:
usel ofl thirdl generationl cephalosporinl canl inducel resistance
QUESTION
Amp-Cl B-lactamasesl producingl bacterial commonl diseases
Answer:
seenl inl thel followingl bacteria:
2026/l 2027l Update)l Adultl Gerontologyl
Acutel Carel Guide|l Questionsl &l Answersl
|l Gradel A|l 100%l Correctl (Verifiedl
Solutions)-l UTA
QUESTION
clinicall pearlsl forl MRSA
Answer:
treatl withl vancomycin,l linexolid,l daptomycin
clindamycin,l trimethoprim/sulfamethoxazole,l andl rifampinl mayl bel usedl too
QUESTION
riskl factorsl forl VRE
Answer:
recentl usel ofl vancomycin,l cephalosporinsl orl quinolonesl
prolongedl hospitalizationl
icul admission
severelyl ill
QUESTION
clinicall pearlsl forl VRE
Answer:
treatl withl ampicillinl ifl sensitive,l linezolid,l daptomycin
mayl colonizel thel skin,l woundsl orl rectum
,QUESTION
beta-lactamasel producingl bacterial riskl factors
Answer:
B-lactamasesl arel enzymesl producedl byl somel bacterial whichl confersl resistantl tol betal
lactaml antibioticsl byl cleavingl thel antibioticl andl makingl itl ineffective
3l types,l ESBL,l Ampl C,l andl carbapenemases
QUESTION
extendedl spectruml b-lactamasesl (ESBL)l riskl factors
Answer:
prolongedl hospitalization
nursingl homel resident
usel ofl thirdl genl cephalosporins,l aztreonam
gutl colonization
inwellingl catheter
severityl ofl illness
QUESTION
extendedl spectruml b-lactamasesl commonl diseases
Answer:
escherichial spp.l andl klebsiellal spp.l arel thel mostl commonl producersl
confersl resistancel tol cegriaxone,l cefazidime,l cefotacime,l aztreonam,l andl penicillins
QUESTION
extendedl spectruml b-lactamasesl clinicall pearls
Answer:
treatmentl ofl choicel isl carbapenems
, QUESTION
carbapenemasesl (akal carbapeneml resistant)l riskl factors
Answer:
thesel bacterial tenl tol colonizel andl infectl patientsl withl multiplel co-morbidities,l ICUl
patientsl andl thosel withl prolongedl hospitlaization
QUESTION
carbapenemasesl commonl diseases
Answer:
klebsiellal spp.l isl thel mostl commonl producerl butl itl mayl bel producedl byl e.l colil .
enterobacterl spp.l pseudomonasl spp.l andl salmonella
QUESTION
carbapendemasesl clinicall pearls
Answer:
treatl withl Colistin.l Tigecyclinel mayl bel anl optionl
IDl consultation
QUESTION
Amp-l Cl B-lactamasesl producingl bacterial riskl factors
Answer:
usel ofl thirdl generationl cephalosporinl canl inducel resistance
QUESTION
Amp-Cl B-lactamasesl producingl bacterial commonl diseases
Answer:
seenl inl thel followingl bacteria:
